Share this post on:

Name :
Recombinant Human FCRL5 protein, His-Avi-tagged

Specification :
| Description : FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE), a potent anti-mitotic agent. | Source : HEK293 | Species : Human | Tag : His-Avi | Form : Supplied as 0.22μm filtered solution in PBS(pH 7.4). | Molecular Mass : The protein has a predicted MW of 94.2 kDa. Due to glycosylation, the protein migrates to 95-115kDa based on Bis-Tris PAGE result. | Protein length : Glu16-Gly851 | Endotoxin : Less than 0.05 EU per μg by the LAL method. | Purity : >95% as determined by Bis-Tris PAGE; >95% as determined by HPLC | Storage : The product should be stored at -70°C. Please do not repeated freeze-thaw cycles.

Gene Information :
| Gene Name : FCRL5 | Official Symbol : FCRL5 | Synonyms : FcR-like protein 5, FcRH5, FcRL5, BXMAS1, Fc receptor homolog 5 | Gene ID : 83416 | mRNA Refseq : NM_001195388.2 | Protein Refseq : NP_001182317.1 | MIM : 605877 | UniProt ID : Q96RD9

MedChemExpress (MCE) recombinant proteins include: cytokines, enzymes, growth factors, hormones, receptors, transcription factors, antibody fragments, etc. They are often essential for supporting cell growth, stimulating cell signaling pathways, triggering or inhibiting cell differentiation; and are useful tools for elucidating protein structure and function, understanding disease onset and progression, and validating pharmaceutical targets. At MedChemExpress (MCE), we strive to provide products with only the highest quality. Protein identity, purity and biological activity are assured by our robust quality control and assurance procedures.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
NMNAT1 Proteinmanufacturer
Myoglobin Proteinsite
Popular categories:
Ubiquitin Conjugating Enzyme E2 L3
Complement Component 8

Share this post on:

Author: Cholesterol Absorption Inhibitors